Stephen Ruoss, MD
Critical Care Medicine · Stanford, CANPI 1255472858
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,045 of the $13,505 with a category attached, or 81.8%. Insmed, Inc. accounts for 85.7% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $11,233, more than ten times the $400 reported in 2019. Among critical care medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $675.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$12K
- Paratek Pharmaceuticals, Inc.$2K
- Mannkind Corporation$130
Across 243 payments — averaging $2556.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Insmed, Inc.$518K
- Paratek Pharmaceuticals, Inc.$77K
- Mannkind Corporation$26K
What the payments were for
- Consulting fees$11,04582%
- Travel & lodging$1,77713%
- Food & beverage$6835%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 16 | $11,576 |
| Paratek Pharmaceuticals, Inc. | 3 | $1,799 |
| Mannkind Corporation | 1 | $130 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,505 in reported general payments places this provider in the 90th percentile of 715 critical care medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $10,097 |
| Sirolimus | 26 | $9,541 |
| Everolimus | 11 | $6,910 |
| Ethambutol Hcl | 27 | $3,243 |
| Azithromycin | 32 | $1,428 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Stanford
- Vanessa MollStanford$106K
- Roberto BernardoStanford$97K
- Roger MeccaStanford$40K
- Harmeet BediStanford$40K
- Carlos BrunStanford$17K
- Michelle CaoStanford$10K
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
- Stephen ChenMonterey Park$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.